Rentokil
RTO
210 hedge funds and large institutions have $1.5B invested in Rentokil in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.
152% more call options, than puts
Call options by funds: $1.78M | Put options by funds: $707K
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
0.07% less ownership
Funds ownership: 2.67% → 2.6% (-0.07%)
7% less funds holding
Funds holding: 227 → 210 (-17)
10% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 77
12% less capital invested
Capital invested by funds: $1.71B → $1.5B (-$202M)
27% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sunriver Management
Greenwich,
Connecticut
|
+$23M |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$11.6M |
| 3 |
VC
Voss Capital
Houston,
Texas
|
+$9.21M |
| 4 |
GCM
Gates Capital Management
New York
|
+$8.62M |
| 5 |
MMRF
Michelson Medical Research Foundation
Los Angeles,
California
|
+$7.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$28.9M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$16.8M |
| 3 |
Goldman Sachs
New York
|
-$11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.7M |
| 5 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
-$8.56M |
RTO Hedge Fund Activity: Q1 2025 in Review
210 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q1 2025, worth a combined $1.5B — down 12% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of RTO and 32 opened new positions — a net loss of 12 holders — while 77 trimmed existing stakes and 69 added.
The largest buyer was Sunriver Management, opening a new position worth an estimated $23M. The largest seller was Manulife (Manufacturers Life Insurance), exiting entirely with an estimated $28.9M sold.
- 210 institutional investors held Rentokil (RTO) as of Q1 2025, down from 227 in Q4 2024.
- Funds reported $1.5B of Rentokil stock for Q1 2025, down 12% quarter-over-quarter.
- 32 funds opened new Rentokil positions in Q1 2025 and 44 closed out, a net change of -12 holders.
- The largest Rentokil buyer in Q1 2025 was Sunriver Management, an estimated $23M added.
- The largest Rentokil seller in Q1 2025 was Manulife (Manufacturers Life Insurance), an estimated $28.9M sold.
Based on aggregated 13F filings for Q1 2025.